STB
GILD icon

S&T Bank’s Gilead Sciences GILD Stock Holding History

S&T Bank’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Buy
217
+26
+14% +$3.43K 0.01% 203
2026
Q1 		$26.6K Sell
191
-81
-30% -$11.3K 0.01% 202
2025
Q4 		$33.4K Buy
272
+111
+69% +$13.5K 0.01% 180
2025
Q3 		$17.9K Sell
161
-267
-62% -$30.3K 0.01% 215
2025
Q2 		$47.5K Buy
428
+44
+11% +$4.68K 0.01% 167
2025
Q1 		$43K Buy
+384
New +$39.6K 0.01% 168

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

S&T Bank's GILD Position: Q2 2026 in Review

S&T Bank increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $3.43K and bringing the position to 217 shares worth $27.4K. The position accounts for 0.01% of the portfolio, ranked #203.

S&T Bank first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. The position peaked at $47.5K in Q2 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • S&T Bank held 217 shares of Gilead Sciences worth $27.4K as of Q2 2026.
  • S&T Bank bought 26 Gilead Sciences shares in Q2 2026, an estimated $3.43K.
  • Gilead Sciences made up 0.01% of S&T Bank's portfolio in Q2 2026, its #203 holding.
  • S&T Bank first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • S&T Bank's Gilead Sciences position peaked at $47.5K in Q2 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on S&T Bank's 13F filing for Q2 2026, filed 12 Aug 2026.